RA Medical Systems

Company Profile

RA Medical Systems had its IPO on 2018-08-30 under the ticker symbol RMED.

The company operates in the Healthcare sector and Medical Devices industry. RA Medical Systems has a staff strength of 14 employees.

Stock update

Shares of RA Medical Systems opened at $0.55 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.55 - $0.57, and closed at $0.57.

This is a +5.56% increase from the previous day's closing price.

A total volume of 39,465 shares were traded at the close of the day’s session.

In the last one week, shares of RA Medical Systems have increased by +2.24%.

RA Medical Systems's Key Ratios

RA Medical Systems has a market cap of $3.84 million, indicating a price to book ratio of 0.8587 and a price to sales ratio of 604.0572.

In the last 12-months RA Medical Systems’s revenue was $90000 with a gross profit of $-1538000 and an EBITDA of $-26205000. The EBITDA ratio measures RA Medical Systems's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, RA Medical Systems’s operating margin was -30760% while its return on assets stood at -47.89% with a return of equity of -325.25%.

In Q1, RA Medical Systems’s quarterly earnings growth was a positive 0% while revenue growth was a positive 844.4%.

RA Medical Systems’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-35.78 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into RA Medical Systems’s profitability.

RA Medical Systems stock is trading at a EV to sales ratio of 41.7907 and a EV to EBITDA ratio of 0.0387. Its price to sales ratio in the trailing 12-months stood at 604.0572.

RA Medical Systems stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$48.51 million

Total Liabilities

$4.45 million

Operating Cash Flow

$0

Capital Expenditure

$37000

Dividend Payout Ratio

0%

RA Medical Systems ended 2024 with $48.51 million in total assets and $0 in total liabilities. Its intangible assets were valued at $48.51 million while shareholder equity stood at $35.86 million.

RA Medical Systems ended 2024 with $0 in deferred long-term liabilities, $4.45 million in other current liabilities, in common stock, $-271537000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $12.22 million and cash and short-term investments were $12.22 million. The company’s total short-term debt was $51,000 while long-term debt stood at $0.

RA Medical Systems’s total current assets stands at $12.76 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $80000.00 compared to accounts payable of $580000.00 and inventory worth $70000.00.

In 2024, RA Medical Systems's operating cash flow was $0 while its capital expenditure stood at $37000.

Comparatively, RA Medical Systems paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.57

52-Week High

$9.085

52-Week Low

$0.4808

Analyst Target Price

$12

RA Medical Systems stock is currently trading at $0.57 per share. It touched a 52-week high of $9.085 and a 52-week low of $9.085. Analysts tracking the stock have a 12-month average target price of $12.

Its 50-day moving average was $0.65 and 200-day moving average was $2.01 The short ratio stood at 0.13 indicating a short percent outstanding of 0%.

Around 3684.9% of the company’s stock are held by insiders while 1100.4% are held by institutions.